Literature DB >> 11401979

Growth phase-dependent invasion of Pseudomonas aeruginosa and its survival within HeLa cells.

U Ha1, S Jin.   

Abstract

Clinical isolates of Pseudomonas aeruginosa are classified into invasive and noninvasive (cytolytic) strains. In a noninvasive PA103 background, ExoS and ExoT have recently been shown to function as anti-internalization factors. However, these two factors seemed not to have such a function in an invasive strain PAK background. In this study, using HeLa tissue culture cells, we observed that the internalization of invasive strain PAK is dependent on its growth phases, with the stationary-phase cells internalized about 100-fold more efficiently than the exponential-phase cells. This growth phase-dependent internalization was not observed in the noninvasive PA103 strain. Further analysis of various mutant derivatives of the invasive PAK and the noninvasive PA103 strains demonstrated that ExoS or ExoT that is injected into host cells by a type III secretion machinery functions as an anti-internalization factor in both types of strains. In correlation with the growth phase-dependent internalization, the invasive strain PAK translocates much higher amount of ExoS and ExoT into HeLa cells when it is in an exponential-growth phase than when it is in a stationary-growth phase, whereas the translocation of ExoT by the noninvasive strain PA103 is consistently high regardless of the growth phases, suggesting a difference in the regulatory mechanism of type III secretion between the two types of strains. Consistent with the invasive phenotype of the parent strain, an internalized PAK derivative survived well within the HeLa cells, whereas the viability of internalized PA103 derivative was dramatically decreased and completely cleared within 48 h. These results indicate that the invasive strains of P. aeruginosa have evolved the mechanism of intracellular survival, whereas the noninvasive P. aeruginosa strains have lost or not acquired the ability to survive within the epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401979      PMCID: PMC98512          DOI: 10.1128/IAI.69.7.4398-4406.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.

Authors:  U M Goehring; G Schmidt; K J Pederson; K Aktories; J T Barbieri
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.

Authors:  A J Vallis; V Finck-Barbançon; T L Yahr; D W Frank
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.

Authors:  K J Pederson; A J Vallis; K Aktories; D W Frank; J T Barbieri
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

Review 4.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

5.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Invasion and intracellular survival of Burkholderia cepacia.

Authors:  D W Martin; C D Mohr
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.

Authors:  D Dacheux; B Toussaint; M Richard; G Brochier; J Croize; I Attree
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients.

Authors:  D Asboe; V Gant; H M Aucken; D A Moore; S Umasankar; J S Bingham; M E Kaufmann; T L Pitt
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

9.  Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.

Authors:  A J Vallis; T L Yahr; J T Barbieri; D W Frank
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells.

Authors:  B A Cowell; D Y Chen; D W Frank; A J Vallis; S M Fleiszig
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

View more
  24 in total

1.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Regulatory role of PopN and its interacting partners in type III secretion of Pseudomonas aeruginosa.

Authors:  Hongjing Yang; Zhiying Shan; Jaewha Kim; Weihui Wu; Wei Lian; Lin Zeng; Laijun Xing; Shouguang Jin
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

3.  The posttranscriptional regulator RsmA plays a role in the interaction between Pseudomonas aeruginosa and human airway epithelial cells by positively regulating the type III secretion system.

Authors:  Heidi Mulcahy; Julie O'Callaghan; Eoin P O'Grady; Claire Adams; Fergal O'Gara
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Mechanism of transcriptional activation by Pseudomonas aeruginosa ExsA.

Authors:  Christopher A Vakulskas; Keith M Brady; Timothy L Yahr
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

5.  Nucleoside diphosphate kinase and flagellin from Pseudomonas aeruginosa induce interleukin 1 expression via the Akt/NF-κB signaling pathways.

Authors:  Yong-Jae Kim; Jung-Hoon Lee; Yeji Lee; Jingyue Jia; Se-Hwan Paek; Hyong-Bai Kim; Shouguang Jin; Un-Hwan Ha
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

6.  The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization.

Authors:  A Kierbel; A Gassama-Diagne; K Mostov; J N Engel
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

7.  Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.

Authors:  Fiona Rodrigues; Mitali Sarkar-Tyson; Sarah V Harding; Siew Hoon Sim; Hui Hoon Chua; Chi Ho Lin; Xu Han; R Krishna M Karuturi; Ken Sung; Kun Yu; Wei Chen; Timothy P Atkins; Richard W Titball; Patrick Tan
Journal:  J Bacteriol       Date:  2006-09-22       Impact factor: 3.490

8.  Up-regulation of bradykinin B2 receptor by Pseudomonas aeruginosa via the NF-κB pathway.

Authors:  Hee-Sung Shin; Un-Hwan Ha
Journal:  Curr Microbiol       Date:  2011-05-31       Impact factor: 2.188

9.  PtrB of Pseudomonas aeruginosa suppresses the type III secretion system under the stress of DNA damage.

Authors:  Weihui Wu; Shouguang Jin
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

10.  Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes.

Authors:  Julien M Buyck; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.